|
Partners Group Private Equity Ltd on Wednesday reported an up to €15 million buyback programme, as it noted positive quarterly cash flow. Partners Group Private Equity is an investment holding company that backs private equity direct investments. It is managed by Partners Group AG, a Swiss-listed private markets investor. PGPE reported that under the terms of its capital allocation policy adopted in March last year, free cash flow at the end of the third quarter was marginally positive at €5.4 million. The company said it has decided to uplift the amount available for buybacks to up to €15 million from €2.7 million, as it noted increasing activity in its portfolio, a persistent discount to net asset value and the expectations that 2025 projected distributions will exceed the €140 million in 2024. Partners Group Private Equity said the buyback will begin once proceeds are received from the PCI transaction announced back in July, with these expected this month. It expects the programme to be implemented over the period to January 31 next year. In July, PGPE said Partners Group agreed to exit its existing stake in PCI Pharma Services and reinvest as a minority shareholder. The transaction valued Partners Group Private Equity’s stake in PCI at around €83 million, in line with a recent carrying value. Under the deal, Partners Group will reinvest €18 million to retain a minority position in the company and support its next phase of growth. PGPE said it last undertook share buybacks back in 2014. It added that there is no certainty on the volume of shares that may be acquired under the scheme, and on the pace of the acquisitions. Shares in the company rose 0.5% to €10.85 on Wednesday morning in London. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
